Search IPOs
Grey Market Premium · Jul 14 – Jul 16, 2025 · Issue Price ₹570
The Anthem Biosciences IPO GMP today is ₹179.00, indicating 31.4% expected listing gain.
The Anthem Biosciences IPO Grey Market Premium (GMP) is currently trading at ₹179.00 in the unofficial grey market. Based on this, the expected listing price is ₹749.00, implying a +31.4% gain over the issue price of ₹570. GMP reflects pre-listing demand from grey market participants and is a widely tracked sentiment indicator among IPO investors.
Grey market premium over time (₹)
Latest 3 data points, most recent first
| Date / Time | GMP (₹) | Exp. Listing | Exp. Gain |
|---|---|---|---|
| Jul 21, 2025 12:00 am | +₹179.00 | ₹749.00 | +31.4% |
| Jul 20, 2025 12:00 am | +₹177.00 | ₹747.00 | +31.1% |
| Jul 19, 2025 12:00 am | +₹163.00 | ₹733.00 | +28.6% |
Want to understand how GMP works and how to estimate listing price? Read our guide on What is GMP in IPO.
The current Grey Market Premium for Anthem Biosciences IPO is ₹179.00 as of Jul 21, 2025. Expected listing price: ₹749.00, expected gain: 31.4%. GMP data is updated periodically from grey market sources.
A GMP of ₹179.00 means that in the unofficial grey market, Anthem Biosciences IPO shares are trading at ₹179.00 above the issue price. With an issue price of ₹570, this implies an expected listing at ₹749.00 (31.4% gain). GMP is purely indicative and actual listing price depends on market conditions.
GMP is an unofficial, unregulated indicator from the informal grey market. It reflects speculative pre-listing demand but can be manipulated or change rapidly. Use it as one data point alongside official subscription data, company financials, and valuation metrics. SEBI does not regulate grey market trading.
Anthem Biosciences IPO is expected to list on July 21, 2025 on NSE,BSE. The GMP on listing day is a strong short-term indicator of opening price.
GMP is unofficial and unregulated. Past GMP accuracy varies. Use alongside subscription data and fundamentals.
